ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2014
Corrections to "A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma".
A M Evens et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.